quinazolines has been researched along with Prostatitis in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 9 (81.82) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alexander, RB; Anderson, RU; Berger, R; Chuai, S; Krieger, JN; Kusek, JW; Landis, JR; Liong, ML; Litwin, MS; McNaughton-Collins, M; Nadler, R; Nickel, JC; Nyberg, LM; O'Leary, M; Pontari, M; Schaeffer, AJ; Shoskes, DA; White, PC; Zeitlin, S | 1 |
| Wagenlehner, FM; Weidner, W | 1 |
| Kattan, MW; Nickel, JC; Shoskes, DA | 1 |
| Alas, P; Helström, PJ; Mehik, A; Nickel, JC; Sarpola, A | 1 |
| Bartoletti, R; Cai, T; Carini, M; Gavazzi, A; Geppetti, P; Giubilei, G; Gontero, P; Mondaini, N; Ungar, A | 1 |
| Lowe, FC; Santillo, VM | 1 |
| Ceriani, I; de Eguileor, M; Del Nero, A; Magri, V; Mangiarotti, B; Marras, E; Montanari, E; Perletti, G; Trinchieri, A; Vral, A; Zirpoli, P | 1 |
| Ceriani, I; Magri, V; Marras, E; Perletti, G; Trinchieri, A | 1 |
| Benemei, S; Geppetti, P; Materazzi, S; Nassini, R | 1 |
| Nickel, JC | 1 |
| de Boo, T; de la Rosette, JJ; Debruyne, FM; Karthaus, HF; van Kerrebroeck, PE | 1 |
3 review(s) available for quinazolines and Prostatitis
| Article | Year |
|---|---|
The management of chronic prostatitis in men with HIV.
Topics: Adrenergic alpha-Antagonists; Algorithms; Antiretroviral Therapy, Highly Active; Chronic Disease; Comorbidity; Cystoscopy; HIV Infections; Humans; Male; Pelvic Pain; Prostatitis; Quercetin; Quinazolines; Sulfonamides; Tamsulosin; Urodynamics | 2006 |
The concept of neurogenic inflammation.
Topics: Adrenergic alpha-Antagonists; Animals; Calcium Channels; Humans; Male; Nerve Tissue Proteins; Neurogenic Inflammation; Prostatism; Prostatitis; Quinazolines; Rats; Transient Receptor Potential Channels; TRPA1 Cation Channel; TRPV Cation Channels; Urinary Bladder; Urinary Bladder, Overactive | 2008 |
Role of alpha1-blockers in chronic prostatitis syndromes.
Topics: Adrenergic alpha-Antagonists; Anti-Infective Agents; Bacterial Infections; Chronic Disease; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Drug Therapy, Combination; Ejaculation; Humans; Male; Pelvic Pain; Prostatism; Prostatitis; Quality of Life; Quinazolines; Randomized Controlled Trials as Topic; Secondary Prevention; Syndrome | 2008 |
4 trial(s) available for quinazolines and Prostatitis
| Article | Year |
|---|---|
Alfuzosin and symptoms of chronic prostatitis-chronic pelvic pain syndrome.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Chronic Disease; Humans; Male; Middle Aged; Pelvic Pain; Prostatitis; Quinazolines; Severity of Illness Index; Treatment Failure; Young Adult | 2008 |
Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled, pilot study.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Chronic Disease; Double-Blind Method; Humans; Male; Middle Aged; Pain Measurement; Pelvic Pain; Pilot Projects; Prospective Studies; Prostate-Specific Antigen; Prostatitis; Quinazolines; Treatment Outcome; Urodynamics | 2003 |
Alfuzosin (10 mg) does not affect blood pressure in young healthy men.
Topics: Adrenergic alpha-Antagonists; Adult; Blood Pressure; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Follow-Up Studies; Heart Rate; Humans; Male; Prognosis; Prostatitis; Quinazolines; Reference Values; Ureteral Calculi | 2006 |
Research in 'prostatitis syndromes': the use of alfuzosin (a new alpha 1-receptor-blocking agent) in patients mainly presenting with micturition complaints of an irritative nature and confirmed urodynamic abnormalities.
Topics: Adrenergic alpha-Antagonists; Adult; Double-Blind Method; Humans; Male; Middle Aged; Prostatitis; Quinazolines; Syndrome; Urination; Urodynamics | 1992 |
4 other study(ies) available for quinazolines and Prostatitis
| Article | Year |
|---|---|
Prostatitis: no benefit of alpha-blockers for chronic prostatitis.
Topics: Adrenergic alpha-Antagonists; Chronic Disease; Humans; Male; Prostatitis; Quinazolines; Randomized Controlled Trials as Topic | 2009 |
Phenotypically directed multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study using UPOINT.
Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Aged; Benzhydryl Compounds; Chronic Disease; Cohort Studies; Cresols; Drug Therapy, Combination; Follow-Up Studies; Humans; Male; Middle Aged; Muscarinic Antagonists; Pain Measurement; Pelvic Pain; Phenotype; Phenylpropanolamine; Probability; Prospective Studies; Prostatitis; Quinazolines; Risk Assessment; Severity of Illness Index; Tolterodine Tartrate; Treatment Outcome; Young Adult | 2010 |
Reduction of PSA values by combination pharmacological therapy in patients with chronic prostatitis: implications for prostate cancer detection.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Algorithms; Androgen Antagonists; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Biomarkers, Tumor; Biopsy; Ciprofloxacin; Drug Therapy, Combination; Humans; Male; Middle Aged; Plant Extracts; Predictive Value of Tests; Prostate-Specific Antigen; Prostatic Neoplasms; Prostatitis; Quinazolines; Retrospective Studies; Serenoa | 2007 |
Eradication of unusual pathogens by combination pharmacological therapy is paralleled by improvement of signs and symptoms of chronic prostatitis syndrome.
Topics: Adrenergic alpha-Antagonists; Adult; Androgen Antagonists; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacterial Infections; Ciprofloxacin; Drug Therapy, Combination; Humans; Male; Middle Aged; Plant Extracts; Prostatitis; Quinazolines; Serenoa; Treatment Outcome | 2007 |